Administration regimen of h+, k+-atpase inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/415 (2006.01) A61K 31/4439 (2006.01)

Patent

CA 2257405

A new administration regimen giving an extended plasma concentration profile of a H+, K+-ATPase inhibitor. The extended plasma profile is received by two or more consecutive administrations of a unit dose of a H+, K+-ATPase with 0.5- 4 hours interval or by a pharmaceutical composition with extended release, which may be administered once daily.

Nouveau régime d'administration produisant un profil de concentration de plasma étendu d'un inhibiteur de H?+¿, K?+¿-ATPase. Le profil de plasma étendu est reçu par deux ou plusieurs administrations consécutives d'une dose unitaire d'une H?+¿, K?+¿-ATPase avec un intervalle de 0,5 à 4 heures ou par une composition pharmaceutique avec libération prolongée et pouvant être administrée une fois par jour.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Administration regimen of h+, k+-atpase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration regimen of h+, k+-atpase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration regimen of h+, k+-atpase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2043123

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.